Zosano pharma corp (ZSAN)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
License fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

170

306

482

682

1,955

0

0

0

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

143

387

585

796

906

0

0

0

Revenue

0

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

693

1,067

1,478

2,861

0

0

0

Operating expenses
Cost of license fees revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

0

0

0

Research and development

24,283

25,385

27,012

26,425

26,318

25,508

23,684

23,468

21,298

20,118

20,085

19,526

19,461

20,457

20,709

22,212

22,918

20,366

17,424

13,384

11,138

10,953

0

0

0

General and administrative

12,023

11,812

11,181

10,463

9,968

9,357

8,721

8,404

8,320

8,182

8,385

8,359

8,122

8,176

7,655

7,364

7,192

6,315

6,009

5,184

4,535

4,420

0

0

0

Total operating expenses

36,306

37,197

38,704

37,399

36,797

35,376

32,475

31,942

29,688

28,370

28,470

27,885

27,583

28,633

28,364

29,576

30,110

26,681

23,433

18,568

15,673

15,473

0

0

0

Loss from operations

-36,306

-37,197

-38,704

-37,399

-36,797

-35,376

-32,475

-31,942

-29,688

-28,370

-28,470

-27,885

-27,583

-28,633

-28,364

-29,576

-30,015

-26,368

-22,740

-17,501

-14,195

-12,612

0

0

0

Other income (expense)
Interest income

137

207

337

449

446

381

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest Expense

688

523

389

187

264

379

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income (expense), net

-

-

-

-

-

-

-

-

-

-

-849

-1,009

-1,123

-1,192

-1,268

-1,268

-1,388

-1,564

-1,826

0

0

-

0

-

-

Interest expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Other income, net

5

-76

-40

35

37

16

9

0

10

7

-46

-46

-8

-7

-97

-56

-110

-97

52

-135

0

-

0

0

-

Loss before provision for income taxes

-36,852

-37,589

-38,796

-37,102

-36,578

-35,358

0

0

0

-

0

-

-28,714

-29,832

0

0

0

-

-

-

-

-

-

-

-

Provision for income taxes

0

0

0

0

0

0

0

0

0

-

0

-

0

0

0

0

0

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Warrant revaluation income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

137

185

0

0

0

Gain on debt forgiveness

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Loss before gain on debt forgiveness

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Loss on debt extinguishment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

Net Income (Loss) Attributable to Parent

-36,852

-37,589

-38,796

-37,102

-36,578

-35,358

-32,700

-32,404

-30,314

-29,105

-29,365

-28,940

-28,714

-29,832

-29,729

-30,900

-31,959

-28,427

-25,058

-20,122

-16,452

-14,241

0

0

0

Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent

-1

5

0

0

1

-5

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain (loss) on marketable securities, net of tax effect

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-32

-6

-7

-46

-15

-38

0

-

0

0

-

Comprehensive loss

-36,853

-37,584

-38,796

-37,102

-36,577

-35,363

0

0

0

-

-

-

-

-

-29,761

-30,906

-31,966

-28,473

-24,479

-19,792

0

-

0

0

-

Net loss per common share – basic and diluted (in USD per share)

-0.24

-0.40

-0.55

-0.55

-0.79

1.85

-0.68

-0.75

-4.16

-6.29

-0.20

-3.44

-6.89

-41.62

-0.52

-0.54

-0.68

-0.67

-0.72

-0.63

-0.47

-0.84

-0.72

-0.76

-0.46

Weighted-average shares used in computing net loss per common share – basic and diluted (in shares)

36,266

18,861

17,832

16,868

11,973

12,110

11,973

11,753

1,973

-35,282

39,228

1,960

1,016

-35,486

14,259

12,012

11,967

11,967

11,961

11,942

9,786

5,151

5,138

5,116

5,107